Skip to content
Disclosery

ORBIMED ADVISORS LLC: RYTM position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on RYTM, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 322,900 RYTM shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 322,900 shares
    Change vs previous 13F +8,800 shares

    0.68% of the 13F portfolio, value $35,851,587.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 314,100 shares
    Change vs previous 13F +74,300 shares

    0.6% of the 13F portfolio, value $27,317,277.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 239,800 shares
    Change vs previous 13F +24,648 shares

    0.53% of the 13F portfolio, value $25,668,192.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 215,152 shares
    Change vs previous 13F -33,360 shares

    0.52% of the 13F portfolio, value $21,728,200.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 248,512 shares
    Change vs previous 13F -131,488 shares

    0.39% of the 13F portfolio, value $15,703,473.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 380,000 shares
    Change vs previous 13F -20,000 shares

    0.48% of the 13F portfolio, value $20,128,600.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 400,000 shares
    Change vs previous 13F -35,900 shares

    0.46% of the 13F portfolio, value $22,392,000.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 435,900 shares
    Change vs previous 13F not available

    0.42% of the 13F portfolio, value $22,836,801.

    13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).